Literature DB >> 3408688

Inheritance and bleeding in factor XI deficiency.

P H Bolton-Maggs1, B Young Wan-Yin, A H McCraw, J Slack, P B Kernoff.   

Abstract

A study of 20 Jewish and four non-Jewish kindreds transmitting factor XI deficiency (164 individuals) confirmed inheritance to be autosomal with severe deficiency in homozygotes (mean factor XI level 3.8 u/dl, SD 2.91) and partial deficiency in heterozygotes (mean factor XI level 57 u/dl, SD 10.42; normal mean factor XI level 96 u/dl, SD 11.6). The probability of an individual being heterozygous can be predicted from the factor XI level using a graph derived from this data. The accuracy is increased by including the prior probability derived from the pedigree. A high frequency of heterozygote to heterozygote mating was observed in the Jewish families consistent with an estimated gene frequency of 13.4% in this racial group. The relationship between factor XI level and bleeding tendency is poor; a third of heterozygotes had bled excessively after surgery, including six with factor XI levels above 50 u/dl, showing this condition to have clear signs of expression in heterozygotes. The lower limit of the normal range (2 SDs from the mean) was found to be 72 u/dl.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408688     DOI: 10.1111/j.1365-2141.1988.tb02409.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Severe intraabdominal bleeding after transvaginal oocyte retrieval for IVF-ET and coagulation factor XI deficiency: a case report.

Authors:  C Battaglia; G Regnani; S Giulini; L Madgar; A D Genazzani; A Volpe
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

2.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.

Authors:  R Asakai; D W Chung; O D Ratnoff; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  A classification system for cross-reactive material-negative factor XI deficiency.

Authors:  Dmitri V Kravtsov; Paul E Monahan; David Gailani
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

Review 4.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

5.  Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.

Authors:  M Zucker; U Seligsohn; O Salomon; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-06-19       Impact factor: 5.824

6.  An insertion mutation of the bovine Fii gene is responsible for factor XI deficiency in Japanese black cattle.

Authors:  Masaki Kunieda; Takehito Tsuji; Abdol Rahim Abbasi; Maryam Khalaj; Miho Ikeda; Keiko Miyadera; Hiroyuki Ogawa; Tetsuo Kunieda
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

7.  Uneventful cesarean delivery with administration of factor XI concentrate in a patient with severe factor XI deficiency.

Authors:  Georgios Mavromatidis; Konstantinos Dinas; Dimitrios Delkos; Fotios Goutzioulis; Christos Vosnakis; Emmanouel Hatzipantelis; Vassilia Garipidou; David Rousso
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

8.  Postoperative primary adrenal failure from bilateral hemorrhagic adrenal infarction associated with coagulation factor XI deficiency.

Authors:  R Wong; D J Topliss; G L Metz; A M Street
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

9.  Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

Authors:  A H Schmaier; L D Dahl; A J Rozemuller; R A Roos; S L Wagner; R Chung; W E Van Nostrand
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.

Authors:  Gillian N Gidley; Lori A Holle; John Burthem; Paula H B Bolton-Maggs; Feng-Chang Lin; Alisa S Wolberg
Journal:  Blood Adv       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.